During the past decade, Policlinico Santa Maria alle Scotte conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Santa Maria alle Scotte" #1 sponsor was "Associazione Qol-one" with 2 trials, followed by "Azienda Ospedaliero-Universitaria di Modena" with 1 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Gruppo di Ricerca GISSI" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Santa Maria alle Scotte" #1 collaborator was "Azienda Ospedaliera di Perugia" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria Careggi" with 1 trials as a collaborator, "Campus Bio-Medico University" with 1 trials as a collaborator, "Catholic University of the Sacred Heart" with 1 trials as a collaborator and "European Institute of Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Santa Maria alle Scotte" are "Myelodysplastic Syndromes" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Acute Rhinosinusitis" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Policlinico Santa Maria alle Scotte" in a lesser frequency.

Most popular intervention types in "Policlinico Santa Maria alle Scotte" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Eltrombopag/Revolade" (2 trials), "CS-7017" (1 trials), "Docetaxel" (1 trials) and "Fecal microbiota transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Santa Maria alle Scotte" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Santa Maria alle Scotte". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Policlinico Santa Maria alle Scotte, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Santa Maria alle Scotte, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".